Phase I/IIa clinical trial of TB 403 in children and adolescents with medulloblastoma
Phase of Trial: Phase I/II
Latest Information Update: 20 Oct 2017
At a glance
- Drugs THR 317 (Primary)
- Indications Alveolar soft part sarcoma; Ewing's sarcoma; Medulloblastoma; Neuroblastoma
- Focus Adverse reactions
- Sponsors Oncurious
- 20 Oct 2017 According to an ThromboGenics media release, the first 2 out of a planned 4 patient groups have now been recruited.
- 02 May 2016 According to an Oncurious media release, first results from this trial are expected in 2017.
- 02 May 2016 Status changed from not yet recruiting to recruiting, as reported in an Oncurious media release.